APPLIED DNA SCIENCES INC's ticker is APDNW and the CUSIP is 03815U110. A total of 6 filers reported holding APPLIED DNA SCIENCES INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | -66.7% | 281,409 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -40.0% | 281,409 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | +400.0% | 281,409 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -98.6% | 281,409 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $73,000 | -7.6% | 281,409 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $79,000 | +5.3% | 281,409 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $75,000 | -25.7% | 281,409 | 0.0% | 0.01% | -30.0% |
| Q4 2017 | $101,000 | -48.7% | 281,409 | 0.0% | 0.01% | -47.4% |
| Q3 2017 | $197,000 | +74.3% | 281,409 | 0.0% | 0.02% | +72.7% |
| Q2 2017 | $113,000 | -0.9% | 281,409 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $114,000 | -19.1% | 281,409 | 0.0% | 0.01% | -21.4% |
| Q4 2016 | $141,000 | -55.5% | 281,409 | 0.0% | 0.01% | -56.2% |
| Q3 2016 | $317,000 | -1.6% | 281,409 | 0.0% | 0.03% | -5.9% |
| Q2 2016 | $322,000 | -37.0% | 281,409 | 0.0% | 0.03% | -35.8% |
| Q1 2016 | $511,000 | +8.3% | 281,409 | 0.0% | 0.05% | +23.3% |
| Q4 2015 | $472,000 | -81.7% | 281,409 | -67.3% | 0.04% | -81.5% |
| Q3 2015 | $2,580,000 | +114.3% | 860,000 | 0.0% | 0.23% | +135.4% |
| Q2 2015 | $1,204,000 | +33.3% | 860,000 | 0.0% | 0.10% | +33.8% |
| Q1 2015 | $903,000 | +14.7% | 860,000 | +32.3% | 0.07% | +17.5% |
| Q4 2014 | $787,000 | – | 650,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERAL AMERICAN INVESTORS CO INC | 281,409 | $472,000 | 0.04% |
| Ionic Capital Management LLC | 349,859 | $587,000 | 0.04% |
| Benchmark Capital Advisors | 10,000 | $17,000 | 0.01% |
| Creative Planning | 70,600 | $119,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 36,771 | $62,000 | 0.00% |
| NEXT Financial Group, Inc | 1,000 | $1,000 | 0.00% |